Comprehensive Study Guide on General Pathology: Apoptosis and Necrosis

Overview and Definition of Apoptosis

• Definition: Apoptosis is a form of cell death induced by a tightly regulated, programmed cellular suicide process.
• Intrinsic Degradation Mechanism: Cells execute self-destruction by degrading their own nuclear DNA and cytoplasmic proteins through the activation of intrinsic cellular enzymes (specifically caspases).
• Dual Context: Apoptosis occurs under both physiological (normal homeostatic and developmental) and pathological (disease- or injury-induced) conditions.

Physiological Causes of Apoptosis

Apoptosis plays a key role in tissue sculpting, homeostatic maintenance, and the clearance of obsolete or potentially harmful cells under normal physiological conditions:

• Elimination of Excess Cells During Embryogenesis and Development:
  • Required for morphogenesis and normal structural modeling during embryonic development.
  • Example: Loss of web tissues between toes and fingers during digit individualization.
• Elimination of Cells Following Withdrawal of Hormonal Stimuli:
  • Occurs when hormone-dependent tissues undergo involution upon hormone withdrawal.
  • Example: Breakdown of the endometrial lining during the normal menstrual cycle.
• Elimination of Cells Following Withdrawal of Trophic Stimuli:
  • Clears short-lived effector cells once survival signals decrease.
  • Example: Clearance of neutrophils at the end of an acute inflammatory response.
• Elimination of Potentially Harmful Cells:
  • Prevents autoimmune pathology by eliminating self-reactive immune components.
  • Example: Removal of self-reactive lymphocytes during immunological tolerance.

Pathological Causes of Apoptosis

Apoptosis eliminates cells that are damaged beyond repair, genetically altered, or infected, thereby preserving tissue integrity and preventing malignant transformation:

• Removal of Cells with Damaged DNA:
  • Severe DNA damage initiates an apoptotic pathway mediated by tumor suppressor genes.
  • Molecular Cascade: The $p53$ gene (tumor suppressor gene) recognizes DNA-damaged cells $\rightarrow$ Initiates DNA repair $\rightarrow$ If damage is severe and irreversible $\rightarrow$ Triggers apoptosis.
• Elimination of Cells with Excessively Accumulated Misfolded Proteins:
  • Aberrant protein folding leads to organellar stress.
  • Molecular Cascade: Mutations in genes encoding proteins $\rightarrow$ Accumulation of misfolded proteins $\rightarrow$ If accumulation occurs in the Endoplasmic Reticulum (ER) $\rightarrow$ ER stress $\rightarrow$ Apoptotic cell death.
• Elimination of Virally Infected Cells: Direct or immune-mediated destruction of infected cells to prevent viral replication and systemic spread.
• Elimination of Neoplastic Cells: Tumor cells undergoing apoptosis in response to baseline surveillance mechanisms or cell-cycle checkpoints.
• Elimination of Parenchymal Cells: Pathological atrophy in parenchymal organ cells following ductal obstruction.

Morphological Changes During Apoptosis

Apoptosis is defined by specific structural alterations that preserve membrane integrity until final clearance:

• Cell Shrinkage: Dense cytoplasm and tightly packed organelles lead to reduced cell volume.
• Nuclear Condensation (Pyknosis): Chromatin aggregates peripherally under the nuclear membrane into dense, well-defined masses.
• Fragmentation of Nucleus and Cytoplasm: Nuclear disintegration (karyorrhexis) accompanied by cellular fragmentation.
• Formation of Apoptotic Bodies and Cytoplasmic Blebs: The plasma membrane forms outward protrusions (blebs) and pinches off to create membrane-bound vesicles known as apoptotic bodies, which contain cellular organelles and nuclear fragments.
• Engulfment of Apoptotic Bodies by Phagocytes: Apoptotic bodies express external recognition signals that trigger rapid engulfment by phagocytic cells, mainly macrophages, without eliciting an inflammatory response.

Molecular Mechanisms and Pathways of Apoptosis

The apoptotic process is executed in two consecutive phases:

1. Initiation Phase: Pro-enzymates are activated via one of two distinct upstream signaling pathways: the Intrinsic (Mitochondrial) Pathway or the Extrinsic (Death Receptor) Pathway.
2. Execution Phase: Downstream executioner caspases are activated to proteolytically degrade cellular components.

Intrinsic (Mitochondrial) Pathway

The intrinsic pathway is activated by internal cell stress, DNA damage, or loss of survival signals:

• Mitochondrial Injury: Cellular injury leads to increased mitochondrial membrane permeability.
• Activation of $BH3$ Proteins: Stress sensors (such as $BH3$ proteins) become activated.
• Effector Activation: $BH3$ proteins activate pro-apoptotic proteins $BAX$ and $BAK$.
• Release of Cytochrome c: Active $BAX$ and $BAK$ facilitate the release of cytochrome c ($cyt\,c$) from the mitochondrial intermembrane space into the cytosol.
• Apoptosome Assembly: Released $cyt\,c$ binds to Apoptotic Protease Activating Factor-1 ($Apaf\text{-}1$), forming a multi-protein oligomeric complex called the Apoptosome.
• Initiator Caspase Activation: The Apoptosome binds to procaspase-9, activating initiator caspase-9.
• Executioner Activation: Active caspase-9 cleaves and activates executioner caspases ($caspase\text{-}3$ and $caspase\text{-}6$).
• Sequential Pathway:   $\text{Mitochondrial Injury} \rightarrow \text{Increased Mitochondrial Permeability} \rightarrow \text{Activation of } BH3 \text{ Proteins} \rightarrow BH3 \text{ Proteins Activate } BAX \& BAK \text{ (Pro-apoptotic Proteins)} \rightarrow \text{Release of } cyt\,c \text{ from Mitochondria} \rightarrow cyt\,c \text{ Binds to } Apaf\text{-}1 \rightarrow \text{Formation of Apoptosome} \rightarrow \text{Apoptosome Binds to Caspase-9} \rightarrow \text{Activation of Initiator Caspase-9} \rightarrow \text{Activation of Executioner Caspases } (caspase\text{-}3 \& caspase\text{-}6) \rightarrow \text{Execution Phase} \rightarrow \text{Morphological Changes} \rightarrow \text{Cell Death (Apoptosis)}$

Extrinsic (Death Receptor) Pathway

The extrinsic pathway is initiated by extracellular signals engaging specialized plasma membrane death receptors:

• Ligand-Receptor Binding:
  • $TRAIL$ ligand binds to $DR4$ and $DR5$ receptors.
  • $FAS$ Ligand ($FASL$) binds to $CD95$ ($FAS$) receptors.
• Death Domain Complex Assembly: Receptor engagement leads to the association of $FADD$ (FAS-Associated Death Domain) and procaspase-8 with the intracellular death domain of the receptor.
• Initiator Caspase Activation: Procaspase-8 is cleaved into active initiator caspase-8.
• Executioner Activation: Active caspase-8 directly cleaves and activates downstream executioner caspases ($caspase\text{-}3$ and $caspase\text{-}6$).
• Sequential Pathway:   $\text{Ligand Binding } (TRAIL \rightarrow DR4/DR5 \text{ or } FASL \rightarrow CD95/FAS) \rightarrow \text{Association of } FADD \& \text{Procaspase-8 to Death Domain} \rightarrow \text{Activation of Caspase-8} \rightarrow \text{Activation of Executioner Caspases } (caspase\text{-}3 \& caspase\text{-}6) \rightarrow \text{Execution Phase} \rightarrow \text{Morphological Changes in Cell} \rightarrow \text{Cell Death (Apoptosis)}$

Comparative Analysis: Apoptosis vs. Necrosis